Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy
Kelso Pharma, the high-growth specialty pharmaceuticals business, announces that Italian-based Velit Biopharma, acquired in November 2023, will trade as ‘Kelso Pharma Italy’ from today (21 October 2025), as the business gears up for further growth across European markets. The rebranding of Velit Biopharma to Kelso Pharma Italy is a natural next step in the growth […]
Kelso Pharma team returns to Edinburgh for annual all-company meeting
Last week, the Kelso Pharma team travelled to Edinburgh for our annual all-company meeting. As the business continues to grow at pace, so does our team, with lots of energy in the room during our time together. It was fantastic being able to welcome everyone to Scotland and enjoy a couple of days of engaging […]
Kelso Pharma appoints new CFO
Kelso Pharma, the high-growth specialty pharmaceuticals business, announces that Allan Watson, the company’s Chief Financial Officer, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Apposite Capital-backed Kelso Pharma is focused on bringing innovative, value-added, specialty medicines to international healthcare markets, providing products that improve the […]
Kelso Pharma builds for future growth with appointment of life sciences leader as Chief Operating Officer
Kelso Pharma, the growing UK-based specialty pharmaceuticals business, has appointed life sciences leader, Dr. Bee Koen Low, as its first Chief Operating Officer. With over 20 years’ experience in the pharmaceutical industry, Bee brings extensive scientific expertise and understanding of the sector to the role, including in the key areas of: M&A due diligence and […]
Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. A proportion of the funding was used by Kelso Pharma in its acquisition of ALTURiX last […]
Kelso Pharma’s European growth story continues with appointment of new General Manager in Italy
Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, Giovanni Mauri, as General Manager at Velit Biopharma, the Italian-based pharma business that was acquired by Kelso Pharma in November 2023. With a wealth of experience across a variety of key markets in the life sciences sector, Giovanni Mauri specialises in […]
Kelso Pharma acquires UK pharma business, ALTURiX
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Holdings Limited (ALTURiX). The transaction marks a significant step towards Kelso’s vision of building a specialty pharma business of scale in the UK and ultimately […]
Kelso Pharma appoints first Director of Corporate Development as international expansion continues
Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, John Rooper, as Director of Corporate Development as the company eyes further growth across international markets. With a wealth of experience in the life sciences sector after working at Ernst and Young (EY) in a senior Mergers and Acquisitions (M&A) role […]
Stirling Anglian Pharmaceuticals launches new website with focus on providing patients with value-based solutions to healthcare
Stirling Anglian Pharmaceuticals (SAP), part of the Kelso Pharma Group, has launched its brand-new website, focusing on their products, corporate responsibility and plans for sustainability moving forward. SAP is a UK based pharmaceutical company, part of the Kelso Pharma Group, with a purpose of bringing innovative, value added, specialty branded medicines to patients across the […]
Kelso Pharma closes acquisition of Italian specialty pharma company, Velit Biopharma
The acquisition of Italian specialty pharma company, Velit Biopharma (Velit), by UK-based specialty pharma business, Kelso Pharma (Kelso), announced on 13th November 2023, has now closed. This is the first step for Kelso in its European expansion strategy and Velit is now part of the Kelso group of companies, which also includes Glasgow-based Stirling Anglian […]